Researchers have developed ultra-sensitive CAR T cells that may offer a potential therapeutic strategy for targeting solid tumors. These cells have shown promise in preclinical studies, with some reports indicating they can eliminate solid tumors in mice. The development of this cell therapy is ongoing, with regulatory hurdles potentially slowing its progress.